Home » Authors » Omar Ford

Articles by Omar Ford

Deals roundup: Exactech adds Altiva for $25M; Polyone completes buy of GLS

Jan. 4, 2008

BD's new FDA-cleared MRSA test gives results in 2 hours

Jan. 3, 2008

AHIP says with 3-part plan, no one will fall 'between the cracks'

Jan. 1, 2008

Cancer drug is used by Angiotech as new CVC anti-infective

Jan. 1, 2008

Boston Sci gets CE mark for Livian CRT-D Device

Dec. 31, 2007

I-Flow buying AcryMed for $25M; NeuroMetrix purchases EyeTel

Dec. 28, 2007

AHIP says with its 3-part plan none 'falls between the cracks'

Dec. 21, 2007

New venture: Wood ‘sees’ ArcScan’s future in Artemis ultrasound device

Dec. 20, 2007

Angiotech using cancer drug as anti-infective CVC coating

Dec. 20, 2007

Wood sees ArcScan s future in Artemis ultrasound device

Dec. 14, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...